Edward Doherty
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Macrophage Migration Inhibitory Factor
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Atherosclerosis and Cardiovascular Diseases
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
Papers in
-
- Macrophage Migration Inhibitory Factor 5
- Galectins and Cancer Biology 3
- T-cell and B-cell Immunology 2
- Immune Cell Function and Interaction 2
-
- Nuclear Receptors and Signaling 4
- Co-authors
- András Perl (7 shared papers)Robert Hanczko (3 shared papers)Richard Bucala (2 shared papers)Paul E. M. Phillips (3 shared papers)Pathricia V. Tilstam (3 shared papers)Joshua B. Bilsborrow (2 shared papers)Zachary Oaks (1 shared paper)Lisa Francis (2 shared papers)
- Journals
- The Journal of Immunology (2 papers)Antioxidants and Redox Signaling (1 paper)Journal of Clinical Investigation (1 paper)Expert Opinion on Therapeutic Targets (1 paper)PLoS Biology (1 paper)
- Partner nations
- United StatesSpainSouth Korea
In The Last Decade
Edward Doherty
13 papers receiving 854 citations
Edward Doherty's Hit Papers
Peers
Comparison fields: 5 of 82
- Immunology 427
- Rheumatology 260
- Biological Psychiatry 12
- Molecular Biology 259
- Biochemistry 27
Countries citing papers authored by Edward Doherty
This map shows the geographic impact of Edward Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Doherty more than expected).
Fields of papers citing papers by Edward Doherty
This network shows the impact of papers produced by Edward Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Doherty. The network helps show where Edward Doherty may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Doherty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | N ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial Hit paper breakdown → | 2012 | 343 |
| 2 | 2019 | 117 | |
| 3 | 2014 | 83 | |
| 4 | 2009 | 80 | |
| 5 | 2012 | 73 | |
| 6 | 2017 | 65 | |
| 7 | 2008 | 47 | |
| 8 | 2009 | 39 | |
| 9 | 2024 | 9 | |
| 10 | 2011 | 4 | |
| 11 | 2017 | 3 | |
| 12 | 2019 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2026 | 0 |
About Edward Doherty
Edward Doherty is a scholar working on Immunology, Cellular and Molecular Neuroscience, Rheumatology, Epidemiology and Molecular Biology, having authored 14 papers that have together received 865 indexed citations. Recurring topics across this work include Macrophage Migration Inhibitory Factor (5 papers), Nuclear Receptors and Signaling (4 papers), Galectins and Cancer Biology (3 papers), Systemic Lupus Erythematosus Research (3 papers), T-cell and B-cell Immunology (2 papers), Immune Cell Function and Interaction (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper) and Biomedical Research and Pathophysiology (1 paper). The work is most often cited by research in Immunology (427 citations), Rheumatology (260 citations), Biological Psychiatry (12 citations), Molecular Biology (259 citations) and Biochemistry (27 citations). Edward Doherty has collaborated with scholars based in United States, Spain and South Korea. Frequent co-authors include András Perl, Robert Hanczko, Richard Bucala, Paul E. M. Phillips, Pathricia V. Tilstam, Joshua B. Bilsborrow, Zachary Oaks, Lisa Francis, Eduardo Bonilla and Gabriella Miklóssy. Their work appears in journals such as The Journal of Immunology, Antioxidants and Redox Signaling, Journal of Clinical Investigation, Expert Opinion on Therapeutic Targets and PLoS Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.